Equillium (EQ) Change in Receivables (2023 - 2024)
Equillium (EQ) posted quarterly Change in Receivables of -$5.0 million for Q4 2024, down 14632.35% year-over-year from N/an in Q1 2024, and down 465.99% quarter-over-quarter from -$885000.0 in Q3 2024.
Equillium (EQ) Change in Receivables (2023 - 2024) Analysis & Trends
Equillium (EQ) has reported Change in Receivables for 2 consecutive years, with -$5.0 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Change in Receivables fell 14632.35% year-over-year to -$5.0 million; the TTM figure through Dec 2024 stood at -$3.7 million (down 516.39% YoY), while the FY2024 annual figure was -$3.7 million, down 516.39% from the prior year.
- Change in Receivables declined to -$5.0 million in Q4 2024 per EQ's latest filing, from -$885000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $1.3 million in Q1 2024 and bottomed at -$5.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Equillium | 263.86 Mn | 263.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -5.01 Mn |
| Dec 31, 2024 | -5.01 Mn |
| Sep 30, 2024 | -885,000.00 |
| Sep 30, 2024 | -885,000.00 |
| Jun 30, 2024 | 846,000.00 |
| Jun 30, 2024 | 846,000.00 |
| Mar 31, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | -34,000.00 |
| Dec 31, 2023 | -34,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 319,000.00 |
| Jun 30, 2023 | 319,000.00 |
| Mar 31, 2023 | 586,000.00 |
| Mar 31, 2023 | 586,000.00 |